0.1050
+0.0060
+(6.06%)
At close: 3:08:17 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
3,381.2730
--
2,823.9060
3,381.2730
2,140.3200
Cost of Revenue
314.3430
--
787.5390
314.3430
225.3180
Gross Profit
3,066.9300
--
2,036.3670
3,066.9300
1,915.0020
Operating Expense
6,658.6300
6,658.6300
5,736.9740
5,816.0600
4,706.3570
Operating Income
-6,658.6300
-6,658.6300
-3,700.6070
-2,749.1300
-2,791.3550
Net Non Operating Interest Income Expense
24.4680
24.4680
-0.8370
-87.9750
-64.2680
Other Income Expense
-2,265.7630
-2,265.7630
-2,510.1160
1,128.8960
1,516.6070
Pretax Income
-8,899.9250
-8,899.9250
-6,211.5600
-1,708.2090
-1,337.3100
Net Income Common Stockholders
-7,673.1530
-7,673.1530
-6,211.5600
-1,708.2090
-1,337.3100
Basic EPS
-0.02
--
-0.02
-0.01
-0.00
Diluted EPS
-0.02
--
-0.02
-0.01
-0.00
Basic Average Shares
370,810.9190
--
321,009.0350
316,884.8890
315,740.3390
Diluted Average Shares
370,810.9190
--
321,009.0350
316,884.8890
315,740.3390
Net Income from Continuing & Discontinued Operation
-7,673.1530
-7,673.1530
-6,211.5600
-1,708.2090
-1,337.3100
Normalized Income
-5,792.4490
-5,792.4490
-2,706.0780
-1,708.2090
-1,337.3100
Interest Income
24.4680
24.4680
81.0250
0.5360
14.7180
Interest Expense
88.5110
--
81.8620
88.5110
78.9860
Net Interest Income
24.4680
24.4680
-0.8370
-87.9750
-64.2680
EBIT
-6,658.6300
-6,658.6300
-6,129.6980
-1,619.6980
-1,258.3240
EBITDA
-6,656.9890
-6,656.9890
-5,803.1490
-1,304.7710
-958.3550
Reconciled Cost of Revenue
314.3430
--
787.5390
314.3430
225.3180
Reconciled Depreciation
1.6410
1.6410
326.5490
314.9270
299.9690
Net Income from Continuing Operation Net Minority Interest
-8,899.9250
-8,899.9250
-6,211.5600
-1,708.2090
-1,337.3100
Total Unusual Items Excluding Goodwill
-3,107.4760
-3,107.4760
-3,505.4820
--
--
Total Unusual Items
-3,107.4760
-3,107.4760
-3,505.4820
--
--
Normalized EBITDA
-3,549.5130
-3,549.5130
-2,297.6670
-1,304.7710
-958.3550
6/30/2021 - 10/6/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
PTX.AX Prescient Therapeutics Limited
0.0420
+2.44%
BTC.AX BTC Health Limited
0.0500
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
CMB.AX Cambium Bio Limited
0.2800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
MEM.AX Memphasys Limited
0.0070
0.00%